1-Phenyl-pyrazole derivatives
    1.
    发明授权
    1-Phenyl-pyrazole derivatives 失效
    1-苯基 - 吡唑衍生物

    公开(公告)号:US4220792A

    公开(公告)日:1980-09-02

    申请号:US6462

    申请日:1979-01-25

    IPC分类号: C07D231/12 C07D231/14

    CPC分类号: C07D231/12 C07D231/14

    摘要: Anti-diabetic agents of the formula: ##STR1## wherein R is CHO or COOR.sub.1, where R.sub.1 is hydrogen or C.sub.1-6 alkyl,R.sub.o is C.sub.1-4 alkyl, C.sub.1-4 alkoxy, bromo, chloro, fluoro, trifluoromethyl, nitro or ##STR2## where R.sub.2 is hydrogen or C.sub.1-4 alkyl, andn is 0 or 1,and the non-toxic, pharmaceutically acceptable salts thereof.

    摘要翻译: 其中R为CHO或COOR1,其中R 1为氢或C 1-6烷基,R 4为C 1-4烷基,C 1-4烷氧基,溴,氯,氟,三氟甲基,硝基或 其中R 2是氢或C 1-4烷基,n是0或1,以及其无毒的药学上可接受的盐。

    1-Phenyl-pyrazole derivatives as glucagon inhibitors
    2.
    发明授权
    1-Phenyl-pyrazole derivatives as glucagon inhibitors 失效
    1-苯基 - 吡唑衍生物作为胰高血糖素抑制剂

    公开(公告)号:US4359474A

    公开(公告)日:1982-11-16

    申请号:US211361

    申请日:1980-11-28

    IPC分类号: C07D521/00 A61K31/415

    摘要: The invention discloses certain 1-phenyl-pyrazole derivatives having pharmacological activity in animals and useful as glucagon inhibiting agents. Nearly all of the compounds of this invention are prepared by cyclization of a phenyl hydrazine compound with a 1,1,3,3-tetra-C.sub.1-4 -alkoxy-propane compound.

    摘要翻译: 本发明公开了在动物中具有药理活性的某些1-苯基 - 吡唑衍生物,可用作胰高血糖素抑制剂。 本发明的几乎所有的化合物都是通过苯基肼化合物与1,1,3,3-四-C 1-4烷氧基 - 丙烷化合物的环化来制备的。

    Azaindole derivatives useful as cholesterol biosynthesis inhibitors
    3.
    发明授权
    Azaindole derivatives useful as cholesterol biosynthesis inhibitors 失效
    可用作胆固醇生物合成抑制剂的Azaindole衍生物

    公开(公告)号:US4939159A

    公开(公告)日:1990-07-03

    申请号:US320664

    申请日:1989-03-08

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: Compounds of the formula I: ##STR1## wherein X is the residue of an unsubstituted 6-membered aromatic ring having 3 carbon atoms and one nitrogen atom;R.sup.1 is C.sub.1-6 primary alkyl (free of asymmetric carbon atoms), or isopropyl;R.sup.2 is substituted or unsubstituted phenyl, primary or secondary C.sub.1-6 alkyl (free of asymmetric carbons),C.sub.3-6 cycloalkyl or phenalkyl as defined in the Specification ##STR2## in which R.sup.8 is hydrogen, R.sup.9 or M, whereinR.sup.9 is a physiologically acceptable and hydrolyzable ester group, andM is a pharmaceutically acceptable cation;are obtained by multi-step processes and are useful as cholesterol biosynthesis inhibitors. 3

    摘要翻译: 式I的化合物:其中X是具有3个碳原子和一个氮原子的未取代的6元芳环的残基; R1是C1-6的伯烷基(不含不对称碳原子)或异丙基; R2是取代或未取代的苯基,主要或仲C 1-6烷基(不含不对称碳),如说明书 中所定义的C 3-6环烷基或苯烷基,其中R 8是氢,R 9或M 其中R9是生理上可接受和可水解的酯基,M是药学上可接受的阳离子; 通过多步法获得并且可用作胆固醇生物合成抑制剂。

    Methods and Apparatus for Forming Hole in Ground
    4.
    发明申请
    Methods and Apparatus for Forming Hole in Ground 审中-公开
    在地面上形成孔的方法和装置

    公开(公告)号:US20150267473A1

    公开(公告)日:2015-09-24

    申请号:US14661837

    申请日:2015-03-18

    申请人: Paul L. Anderson

    发明人: Paul L. Anderson

    IPC分类号: E21B7/02

    CPC分类号: E21B7/028

    摘要: An apparatus for forming a hole in ground (10) includes a mounting plate (60) mounted to a loader (80). A probe (11) is coupled with the mounting plate (60) through a hydraulic motor (120) having an output shaft (122). The probe (11) is driven into the ground along the vertical axis by movement of the mounting plate (60) by the loader (80), and an upper portion of the probe (11) is simultaneously wobbled about two axes that are perpendicular to each other and to the vertical axis while the output shaft (122) is rotating. The probe (11) is then moved out of the ground to leave a hole (100) in the ground. To provide a rolling action against the sides of the hole (100), the upper end of the probe (11) is moved about an annular path around the vertical axis while the probe (11) is rotating.

    摘要翻译: 用于在地面(10)中形成孔的装置包括安装到装载机(80)上的安装板(60)。 探头(11)通过具有输出轴(122)的液压马达(120)与安装板(60)联接。 通过安装板(60)由装载机(80)的移动,探头(11)沿着垂直轴线被驱动到地面中,并且探针(11)的上部同时绕两个垂直于 在输出轴(122)旋转的同时相对于垂直轴。 探头(11)然后移出地面,在地面上留下一个孔(100)。 为了对孔(100)的侧面提供滚动动作,当探头(11)旋转时,探针(11)的上端围绕垂直轴线的环形路径移动。

    Operating system-firmware interface update recovery
    5.
    发明授权
    Operating system-firmware interface update recovery 失效
    操作系统 - 固件界面更新恢复

    公开(公告)号:US08132055B2

    公开(公告)日:2012-03-06

    申请号:US12622969

    申请日:2009-11-20

    IPC分类号: G06F11/00

    摘要: Operating system (‘OS’)-firmware interface update recovery including determining, for each of a plurality of available OS-firmware interface images for booting a computer, whether each available OS-firmware interface image is corrupted or uncorrupted; setting, for each corrupted OS-firmware interface image, a predictive failure analysis (‘PFA’) bit in nonvolatile memory available to the OS-firmware interface update recovery module; selecting an uncorrupted OS-firmware interface image; initiating a boot for the computer with the selected OS-firmware interface image; determining whether a previous update to one of the available OS-firmware interface images was interrupted; and notifying a user that the previous update was interrupted if the previous update to one of the available OS-firmware interface images interrupted.

    摘要翻译: 操作系统(“OS”) - 固件接口更新恢复,包括为每个可用的用于引导计算机的可用OS固件接口图像确定每个可用OS-固件接口图像是否损坏或未被破坏; 对于每个损坏的OS固件界面图像,设置OS固件接口更新恢复模块可用的非易失性存储器中的预测故障分析(“PFA”)位; 选择未被破坏的OS固件界面图像; 使用所选的OS固件界面图像启动计算机的引导; 确定对所述可用OS固件接口图像之一的先前更新是否被中断; 并且如果先前更新到可用的OS固件接口图像之一被中断,则通知用户先前更新被中断。

    Anti-atherosclerotic indolizine derivatives
    7.
    发明授权
    Anti-atherosclerotic indolizine derivatives 失效
    抗动脉粥样硬化中和衍生物

    公开(公告)号:US4751235A

    公开(公告)日:1988-06-14

    申请号:US945750

    申请日:1986-12-23

    申请人: Paul L. Anderson

    发明人: Paul L. Anderson

    IPC分类号: C07D471/04 A61K31/435

    CPC分类号: C07D471/04

    摘要: 7-(indolizin-2-yl)hept-6-enoic acids of the formula I: ##STR1## wherein each of R.sup.1 and R.sup.2 is, independently, H, alkyl, cycloalkyl, aralkyl or aryl, ##STR2## in which R.sup.8 is H, an ester residue or cation; or the lactone thereof. The compounds are useful as hypocholesteremic agents.

    摘要翻译: 7-(中氮茚-2-基)庚-6-烯酸,其中R 1和R 2各自独立地为H,烷基,环烷基,芳烷基或芳基,Y是CHCH或CH 2 CH 2 ; 和其中R 8为H的酯基残基或阳离子的 或其内酯。 该化合物可用作低胆固醇剂。